Role of B7-1 in mediating an immune response to myeloid leukemia cells

作者: UA Matulonis , C Dosiou , C Lamont , GJ Freeman , P Mauch

DOI: 10.1182/BLOOD.V85.9.2507.BLOODJOURNAL8592507

关键词:

摘要: A costimulatory signal from B7-1 (CD80) to its counter-receptor CD28 is required for T-cell activation. Many tumors, including most human leukemias, lack expression of B7-1, and this has been suggested contribute the failure immune recognition these diseases. murine leukemia model system was developed assess potential role in induction immunity cells. The nonleukemic 32Dc13 myeloid cell line transformed by transfection BCR/ABL gene, generating a subline (32Dp210/clone 26) that leukemic rapidly lethal syngeneic, immunocompetent C3H/HeJ mice or T-cell-deficient nude mice. B7-1-modified cells remained mice, but caused only transient, nonlethal After single exposure live, nonirradiated cells, protective against subsequent challenge with B7-1(-) Further, hyperimmunization B7-1(+) prolonged survival previously injected number These results indicate may be attractive candidates gene transfer.

参考文章(42)
Matulonis U, Griffin Jd, Salgia R, Okuda K, Druker B, Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Experimental Hematology. ,vol. 21, pp. 1460- 1466 ,(1993)
G. Yamada, Y. Kitamura, H. Sonoda, H. Harada, S. Taki, R. C. Mulligan, H. Osawa, T. Diamantstein, S. Yokoyama, T. Taniguchi, Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. The EMBO Journal. ,vol. 6, pp. 2705- 2709 ,(1987) , 10.1002/J.1460-2075.1987.TB02563.X
S Ostrand-Rosenberg, V Clements, A Thakur, Rejection of mouse sarcoma cells after transfection of MHC class II genes. Journal of Immunology. ,vol. 144, pp. 4068- 4071 ,(1990)
N Lassam, G Jay, Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. Journal of Immunology. ,vol. 143, pp. 3792- 3797 ,(1989)
E Vellenga, DC Young, K Wagner, D Wiper, D Ostapovicz, JD Griffin, The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia Blood. ,vol. 69, pp. 1771- 1776 ,(1987) , 10.1182/BLOOD.V69.6.1771.1771
S Ostrand-Rosenberg, V K Clements, C A Roby, Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule. Journal of Immunology. ,vol. 147, pp. 2419- 2422 ,(1991)
Jonathan W. Yewdell, Nicholas P. Restifo, Jack R. Bennink, Hans Stötter, Steven A. Rosenberg, James J. Mulé, Fernando Esquivel, Anthony L. Asher, Richard J. Barth, Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response. Journal of Immunology. ,vol. 147, pp. 1453- 1459 ,(1991)
D Guerry, M A Alexander, J Bennicelli, Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. Journal of Immunology. ,vol. 142, pp. 4070- 4078 ,(1989)
L Schiff-Maker, M C Burns, J B Konopka, S Clark, O N Witte, N Rosenberg, Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules. Journal of Virology. ,vol. 57, pp. 1182- 1186 ,(1986) , 10.1128/JVI.57.3.1182-1186.1986